Clinical Trial Update: Does Rosuvastatin Delay Progression of Atherosclerosis in HIV [Phase 4]

View source ↗

Summary

Phase 4 trial updating whether rosuvastatin delays progression of atherosclerosis in people with HIV; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Bayside Health | Conditions: HIV, Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-08-28